Cargando…
On the need to adjust for multiplicity in confirmatory clinical trials with master protocols
Autores principales: | Stallard, N, Todd, S, Parashar, D, Kimani, P K, Renfro, L A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503623/ https://www.ncbi.nlm.nih.gov/pubmed/30715156 http://dx.doi.org/10.1093/annonc/mdz038 |
Ejemplares similares
-
Point estimation following two‐stage adaptive threshold enrichment clinical trials
por: Kimani, Peter K., et al.
Publicado: (2018) -
Adjusting for treatment selection in phase II/III clinical trials with time to event data
por: Khan, Josephine N., et al.
Publicado: (2022) -
Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges
por: Ursino, Moreno, et al.
Publicado: (2021) -
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
por: Kimani, Peter K, et al.
Publicado: (2013) -
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection
por: Kimani, Peter K., et al.
Publicado: (2020)